The Dow Jones closed higher on Tuesday, recording gains for the 12th straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
BioRestorative Therapies
- The Trade: BioRestorative Therapies, Inc. BRTX President, CEO, COB Lance Alstodt acquired a total of 4,200 shares an average price of $2.44. To acquire these shares, it cost around $10,248.
- What’s Happening: BioRestorative Therapies has been granted a license by the New York State Department of Health to operate as a Tissue Bank.
- What BioRestorative Therapies Does: BioRestorative Therapies Inc is a biotechnology company based in the United States.
Brightcove
- The Trade: Brightcove Inc. BCOV 10% owner Jonathan Brolin acquired a total of 30,285 shares at an average price of $3.89. The insider spent around $117,874.
- What’s Happening: Brightcove entered into a strategic agreement with PubMatic PUBM, an independent technology company delivering digital advertising's supply chain of the future.
- What Brightcove Does: Brightcove Inc is a provider of cloud-based services for the video ecosystem. The firm targets its solutions at media companies, broadcasters, publishers, and corporations.
Transphorm
- The Trade: Transphorm, Inc. TGAN 10% owner George Roberts acquired a total of 1,735,988 shares at an average price of $3.30. To acquire these shares, it cost around $5.73 million.
- What’s Happening: Transphorm recently announced commencement of $15 million rights offering.
- What Transphorm Does: Transphorm Inc is a semiconductor company. It designs and manufactures GaN semiconductors for high-voltage power conversion applications.
Check This Out: Fear & Greed Index Remains In 'Extreme Greed' Zone After Dow Notches Longest Winning Streak In Over Six Years
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.